Speaker Details

Daniel M. Siegel, MS, MD, FAAD

Daniel M. Siegel, MS, MD, FAAD

SESSIONS

No sessions scheduled for this speaker.

HANDOUTS

Login to view handouts

DISCLOSURES

Biofrontera AG – Stockholder(Stock); Caliber Imaging and Diagnostics Inc. – Board of Directors(Stock); DermaSensor Inc – Consultant(Honoraria); DermTech Inc. – Advisory Board(No Compensation Received); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Feldan Therapeutics – Consultant(Fees); Greenway Therapeutix – Advisory Board(No Compensation Received), Stockholder(Stock); Lazarus Enterprises Inc. – Consultant(Stock Options); Logical Images – Consultant(Stock Options); MycoMedica Life Sciences – Advisory Board(No Compensation Received); Novascan – Advisory Board(No Compensation Received), Stockholder(No Compensation Received); Omnilux – Advisory Board(Equipment); Or-Genix, Therapeutics – Board of Directors(Stock Options), Stockholder(No Compensation Received); Plasmend – Stockholder(No Compensation Received); Pulse Biosciences – Consultant(Fees); RBC Consultants – Consultant (1099 relationship)(Honoraria); Regeneron – Speaker(Honoraria); Seaspire Skincare – Consultant(Stock Options); SkinVision – Advisory Board(Stock Options); SkinVision BV – Advisory Board(No Compensation Received); SPC Dermatology – Employee(Salary); Strata Skin Sciences – Consultant(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Tetros Group – Advisory Board(No Compensation Received), Stockholder(No Compensation Received); Verrica Pharmaceuticals Inc – Consultant(Fees);